Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (888)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$518.14
Total Value
$558.03K
Shares Held After
328,320
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
773
Price
$517.07
Total Value
$399.69K
Shares Held After
329,397
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,689
Price
$516.15
Total Value
$871.78K
Shares Held After
330,170
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
624
Price
$515.26
Total Value
$321.52K
Shares Held After
331,859
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
271
Price
$513.85
Total Value
$139.25K
Shares Held After
332,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,189
Price
$512.71
Total Value
$609.62K
Shares Held After
332,754
% of Holdings
0.4%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
20,000
Price
$0.65
Total Value
$13.00K
Shares Held After
73,533
% of Holdings
27.2%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
144,756
Price
$36.48
Total Value
$5.28M
Shares Held After
18,630,739
% of Holdings
0.8%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
21,055
Price
$1.60
Total Value
$33.60K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
20,553
Price
$1.59
Total Value
$32.78K
Shares Held After
48,750
% of Holdings
29.7%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
32,018
Price
$4.50
Total Value
$144.08K
Shares Held After
2,433,280
% of Holdings
1.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Curran Terrie — Director
Shares
1,072
Price
$26.04
Total Value
$27.91K
Shares Held After
23,526
% of Holdings
4.4%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
11,899
Price
$1.37
Total Value
$16.30K
Shares Held After
600,117
% of Holdings
2.0%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
202,124
Price
$1.78
Total Value
$359.54K
Shares Held After
4,030,075
% of Holdings
5.0%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
60,677
Price
$47.05
Total Value
$2.85M
Shares Held After
59,086
% of Holdings
50.7%
Intellia Therapeutics, Inc. (NTLA)
LEONARD JOHN M — Director
Shares
19,890
Price
$12.60
Total Value
$250.61K
Shares Held After
1,149,849
% of Holdings
1.7%
Tonix Pharmaceuticals Holding Corp. (TNXP)
BAGGER RICHARD H — Director
Shares
1,000
Price
$12.60
Total Value
$12.60K
Shares Held After
1,000
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
17,519
Price
$37.30
Total Value
$653.46K
Shares Held After
18,630,739
% of Holdings
0.1%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
66,711
Price
$1.51
Total Value
$101.00K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
67,741
Price
$1.51
Total Value
$102.59K
Shares Held After
48,750
% of Holdings
58.2%
OMEROS CORP (OMER)
Cable Thomas J. — Director
Shares
15,000
Price
$18.45
Total Value
$276.77K
Shares Held After
35,067
% of Holdings
30.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
691
Price
$72.92
Total Value
$50.39K
Shares Held After
1,361,594
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
2,390
Price
$71.88
Total Value
$171.79K
Shares Held After
1,362,285
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,419
Price
$70.78
Total Value
$666.68K
Shares Held After
1,364,675
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
193
Price
$526.97
Total Value
$101.71K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$525.10
Total Value
$126.02K
Shares Held After
324,636
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$523.26
Total Value
$418.61K
Shares Held After
324,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
960
Price
$522.37
Total Value
$501.48K
Shares Held After
325,676
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,470
Price
$521.39
Total Value
$1.29M
Shares Held After
326,636
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,357
Price
$520.46
Total Value
$1.23M
Shares Held After
329,106
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,504
Price
$519.51
Total Value
$781.34K
Shares Held After
331,463
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
976
Price
$518.45
Total Value
$506.01K
Shares Held After
332,967
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
120
Price
$527.21
Total Value
$63.27K
Shares Held After
45,172
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
400
Price
$526.38
Total Value
$210.55K
Shares Held After
45,292
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
940
Price
$525.25
Total Value
$493.74K
Shares Held After
45,692
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
192
Price
$523.69
Total Value
$100.55K
Shares Held After
46,632
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
850
Price
$522.78
Total Value
$444.37K
Shares Held After
46,824
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
787
Price
$522.00
Total Value
$410.82K
Shares Held After
47,674
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,819
Price
$521.04
Total Value
$947.77K
Shares Held After
48,461
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
502
Price
$520.03
Total Value
$261.06K
Shares Held After
50,280
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,690
Price
$524.15
Total Value
$1.41M
Shares Held After
50,782
% of Holdings
5.0%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
114,700
Price
$4.54
Total Value
$520.74K
Shares Held After
2,465,298
% of Holdings
4.4%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
3,056
Price
$44.16
Total Value
$134.95K
Shares Held After
219,301
% of Holdings
1.4%
Liquidia Corp (LQDA)
Rielly-Gauvin Katherine — Director
Shares
18,393
Price
$72.23
Total Value
$1.33M
Shares Held After
44,637
% of Holdings
29.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$8.79
Total Value
$439.43K
Shares Held After
800,000
% of Holdings
6.2%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
16,634
Price
$0.59
Total Value
$9.81K
Shares Held After
53,533
% of Holdings
31.1%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
7,342
Price
$62.12
Total Value
$456.09K
Shares Held After
961,194
% of Holdings
0.8%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
36,373
Price
$61.11
Total Value
$2.22M
Shares Held After
968,536
% of Holdings
3.6%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
47,307
Price
$60.17
Total Value
$2.85M
Shares Held After
1,004,909
% of Holdings
4.5%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
6,495
Price
$0.32
Total Value
$2.08K
Shares Held After
7,850,155
% of Holdings
0.1%
Showing 101–150 of 888 transactions (page 3 of 18)